treatment

After treatment, 38.1 percent of patients with head and neck cancer who were employed at the time of cancer diagnosis reported discontinuing work because of their cancer and treatment, according to a report in the May issue of Archives of Otolaryngology-Head & Neck Surgery. "Although most...

Ranbaxy Laboratories Limited (Ranbaxy) today announced the launch of its branded product, Avessa (Formoterol + Fluticasone) inhalation capsules in India for the treatment of Asthma. This unique combination has been launched for the first time in the world combining the fastest acting Long Acting...